• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM S.R.L. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM S.R.L. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVF-M
Device Problem Incomplete Coaptation (2507)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 02/07/2023
Event Type  Injury  
Event Description
On (b)(6) 2023, a perceval plus valve size m was attempted to be implanted.Reportedly, during the echo, a central leak was noted.Furthermore, surgeon discovered ncc cuspid side leaflets were not coaptating.As such, decision was made to explant and re-implanted the valve.However, central leak was still present in the echo imaging.Thus, the valve explanted again.The procedure was completed with a conventional valve, medtronic avalus.After the surgery, the surgeon examined the explanted pvf-m and found that one of the leaflets on the ncc side leaflets is shorter than the other sides.Based on further information received, there was no malfunction identified prior to this event and no mis-sizing was identified.As reported, the procedure was combined coronary artery bypass grafting and aortic valve replacement (cabg-avr), and the patient geometries were not considered abnormal.Patient¿s annulus size was 21mm, and there was no additional debridement or annular restructuring performed prior to the second implant.The procedure was delayed by about one hour.The patient has been in stable condition throughout the procedure and no patient effects have been reposted.
 
Manufacturer Narrative
A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.The valve was returned to the manufacturer.After decontamination, the valve was visually inspected without highlighting elements of non-conformity according to the specifications.For a cardiac output of 5.0 l/min and mean aortic pressure of about 100 mmhg, the regurgitant fraction is 3.9 % and it is below the requirement of iso 5840 (rf% < 10%) for a prosthesis of equivalent tad.No anomalies were observed during the open/close cycle in both normotensive and hypotensive conditions regarding the total and full coaptation of the leaflets.Although a leaflet (i.E.The leaflet #1) appears with an anomalous shape in the relaxed configuration, it is important to highlight that this configuration does not appear either in the images documenting the open/close test, nor in the images documenting the tests performed in the pulse duplicator in hypotensive / normotensive conditions.The observed anomalous shape can be more likely associated to some small undetected deformations that occurred during implantation / explantation or possible non-optimal storage conditions before returning the prosthesis to corcym.However, the observed feature is totally unrelated to the coaptation problem complained of by the customer, which, on the contrary, is probably due to the patient's peculiar anatomy.Based on the performed analysis, the reported event cannot be explained by any factor intrinsic in the involved device because the claimed issues were not observed during the investigation carried out (i.E., hydrodynamic test).It is possible that the patient's peculiar anatomy has contributed to this event.But since limited information is available in this regard, this cannot ultimately be confirmed.Should further information be received in the future, the manufacturer will provide a follow up report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM S.R.L.
strada crescentino
saluggia, vercelli
Manufacturer (Section G)
CORCYM S.R.L.
strada crescentino
saluggia, vercelli
Manufacturer Contact
laura mannino
5005 north fraser way
burnaby, bc 
MDR Report Key16531625
MDR Text Key311208393
Report Number3005687633-2023-00101
Device Sequence Number1
Product Code LWR
UDI-Device Identifier08022057015372
UDI-Public(01)08022057015372(240)PVF-M(17)251212
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011/S013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVF-M
Device Catalogue NumberPVF-M
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/06/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 02/13/2023
Initial Date FDA Received03/13/2023
Supplement Dates Manufacturer Received03/16/2023
Supplement Dates FDA Received04/14/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/13/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-